Cargando…
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy
Background. Systemic immunity and inflammation indexes (SI) derived from blood cells have gained increasing attention in clinical oncology as potential biomarkers that are associated with survival. Materials and methods. We tested 12 different SI using blood tests from patients with isocitrate dehyd...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223226/ https://www.ncbi.nlm.nih.gov/pubmed/35741816 http://dx.doi.org/10.3390/genes13061054 |
_version_ | 1784733074841403392 |
---|---|
author | Pasqualetti, Francesco Giampietro, Celeste Montemurro, Nicola Giannini, Noemi Gadducci, Giovanni Orlandi, Paola Natali, Eleonora Chiarugi, Paolo Gonnelli, Alessandra Cantarella, Martina Scatena, Cristian Fanelli, Giuseppe Nicolò Naccarato, Antonio Giuseppe Perrini, Paolo Liberti, Gaetano Morganti, Riccardo Franzini, Maria Paolicchi, Aldo Pellegrini, Giovanni Bocci, Guido Paiar, Fabiola |
author_facet | Pasqualetti, Francesco Giampietro, Celeste Montemurro, Nicola Giannini, Noemi Gadducci, Giovanni Orlandi, Paola Natali, Eleonora Chiarugi, Paolo Gonnelli, Alessandra Cantarella, Martina Scatena, Cristian Fanelli, Giuseppe Nicolò Naccarato, Antonio Giuseppe Perrini, Paolo Liberti, Gaetano Morganti, Riccardo Franzini, Maria Paolicchi, Aldo Pellegrini, Giovanni Bocci, Guido Paiar, Fabiola |
author_sort | Pasqualetti, Francesco |
collection | PubMed |
description | Background. Systemic immunity and inflammation indexes (SI) derived from blood cells have gained increasing attention in clinical oncology as potential biomarkers that are associated with survival. Materials and methods. We tested 12 different SI using blood tests from patients with isocitrate dehydrogenase 1 and 2 wild-type glioblastomas, treated with radio-chemotherapy. The primary endpoint was their overall survival. Results. A total of 77 patients, comprising 43 males and 34 females, with a median age of 64 years (age range 26–84), who were treated between October 2010 and July 2020, were included in the present analysis (approved by a local ethics committee). In the univariate Cox regression analysis, all the indexes except two showed a statistically significant impact on OS. In the multivariate Cox regression analysis, neutrophil × platelet × leukocyte/(lymphocyte × monocyte) (NPW/LM) and neutrophil × platelet × monocyte/lymphocyte (NPM/L) maintained their statistically significant impact value. Conclusions. This univariate analysis confirms the potential of systemic inflammation indexes in patients with glioblastoma, while the multivariate analysis verifies the prognostic value of NPW/LM and NPM/L. |
format | Online Article Text |
id | pubmed-9223226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92232262022-06-24 Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy Pasqualetti, Francesco Giampietro, Celeste Montemurro, Nicola Giannini, Noemi Gadducci, Giovanni Orlandi, Paola Natali, Eleonora Chiarugi, Paolo Gonnelli, Alessandra Cantarella, Martina Scatena, Cristian Fanelli, Giuseppe Nicolò Naccarato, Antonio Giuseppe Perrini, Paolo Liberti, Gaetano Morganti, Riccardo Franzini, Maria Paolicchi, Aldo Pellegrini, Giovanni Bocci, Guido Paiar, Fabiola Genes (Basel) Article Background. Systemic immunity and inflammation indexes (SI) derived from blood cells have gained increasing attention in clinical oncology as potential biomarkers that are associated with survival. Materials and methods. We tested 12 different SI using blood tests from patients with isocitrate dehydrogenase 1 and 2 wild-type glioblastomas, treated with radio-chemotherapy. The primary endpoint was their overall survival. Results. A total of 77 patients, comprising 43 males and 34 females, with a median age of 64 years (age range 26–84), who were treated between October 2010 and July 2020, were included in the present analysis (approved by a local ethics committee). In the univariate Cox regression analysis, all the indexes except two showed a statistically significant impact on OS. In the multivariate Cox regression analysis, neutrophil × platelet × leukocyte/(lymphocyte × monocyte) (NPW/LM) and neutrophil × platelet × monocyte/lymphocyte (NPM/L) maintained their statistically significant impact value. Conclusions. This univariate analysis confirms the potential of systemic inflammation indexes in patients with glioblastoma, while the multivariate analysis verifies the prognostic value of NPW/LM and NPM/L. MDPI 2022-06-13 /pmc/articles/PMC9223226/ /pubmed/35741816 http://dx.doi.org/10.3390/genes13061054 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pasqualetti, Francesco Giampietro, Celeste Montemurro, Nicola Giannini, Noemi Gadducci, Giovanni Orlandi, Paola Natali, Eleonora Chiarugi, Paolo Gonnelli, Alessandra Cantarella, Martina Scatena, Cristian Fanelli, Giuseppe Nicolò Naccarato, Antonio Giuseppe Perrini, Paolo Liberti, Gaetano Morganti, Riccardo Franzini, Maria Paolicchi, Aldo Pellegrini, Giovanni Bocci, Guido Paiar, Fabiola Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy |
title | Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy |
title_full | Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy |
title_fullStr | Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy |
title_full_unstemmed | Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy |
title_short | Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy |
title_sort | old and new systemic immune-inflammation indexes are associated with overall survival of glioblastoma patients treated with radio-chemotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223226/ https://www.ncbi.nlm.nih.gov/pubmed/35741816 http://dx.doi.org/10.3390/genes13061054 |
work_keys_str_mv | AT pasqualettifrancesco oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT giampietroceleste oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT montemurronicola oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT giannininoemi oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT gadduccigiovanni oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT orlandipaola oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT natalieleonora oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT chiarugipaolo oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT gonnellialessandra oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT cantarellamartina oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT scatenacristian oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT fanelligiuseppenicolo oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT naccaratoantoniogiuseppe oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT perrinipaolo oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT libertigaetano oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT morgantiriccardo oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT franzinimaria oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT paolicchialdo oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT pellegrinigiovanni oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT bocciguido oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy AT paiarfabiola oldandnewsystemicimmuneinflammationindexesareassociatedwithoverallsurvivalofglioblastomapatientstreatedwithradiochemotherapy |